Nutritional management of lipids for overweight and obesity: What can we achieve?

Future Lipidology

Volumn 3, Issue 5, 2008, Pages 573-584

  Hill, Alison M ^a   Roussell, Michael A ^a   Kris Etherton, Penny M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

C reactive protein; Diet intervention; Inflammation; Insulin resistance; Lipids; Lipoproteins; Obesity

Indexed keywords

CARBOHYDRATE; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID;

BODY WEIGHT; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; DIET RESTRICTION; DIETARY INTAKE; FAT INTAKE; FEEDING BEHAVIOR; HUMAN; LIFESTYLE MODIFICATION; LOW FAT DIET; MACRONUTRIENT; MEDITERRANEAN DIET; NUTRITIONAL REQUIREMENT; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; WEIGHT REDUCTION;

EID: 55849129990     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.3.5.573     Document Type: Review

References (77)

1. Levi J, Gadola E, Segal LM: F as in fat: how obesity policies are failing in America. Trust for America's Health, Washington, DC, USA (2007).
2. Eckel RH: Obesity and heart disease: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 96, 3248-3250 (1997).
3. Rabkin SW, Mathewson FAL, Hsu P-H: Relation of body weight to development of ischemic heart disease in a cohort of young north American men after a 26 year observation period: the Manitoba study. Am. J. Cardiol. 39, 452-458 (1977).
4. Manson JE, Willett WC, Stampfer MJ et al.: Body weight and mortality among women. N. Engl. J. Med. 333, 677-685 (1995).
5. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L: Adolescent overweight and future adult coronary heart disease. N. Engl. J. Med. 357, 2371-2379 (2007).
6. Wilson PWF, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and Type 2 diabetes mellitus. Circulation 112, 3066-3072 (2005).
7. Bastard JP, Maachi M, Lagathu C et al.: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12 (2006).
8. National Cholesterol Education Panel (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106, 3143-3421 (2002).
9. Bansal S, Buring JE, Rifai N et al.: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309-316 (2007).
10. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299-308 (2007).
11. Castelli WP, Anderson K, Wilson PW, Levy D: Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2, 23-28 (1992).
12. Mozaffarian D: Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence. Curr. Atheroscler. Rep. 7, 435-445 (2005).
13. Yancy WS Jr, Westman EC, French PA, Califf RM: Diets and clinical coronary events: the truth is out there. Circulation 107, 10-16 (2003).
14. Dattilo AM, Kris-Etherton PM: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am. J. Clin. Nutr. 56, 320-328 (1992).
15. Lee M, Aronne LJ: Weight management for Type 2 diabetes mellitus: global cardiovascular risk reduction. Am. J. Cardiol. 99, 68-79 (2007).
16. Roussell M, Kris-Etherton P: Effects of lifestyle interventions on high-density lipoprotein cholesterol levels. J. Clin. Lipidol. 1, 65-73 (2007).
17. Lichtenstein AH, Appel LJ, Brands M et al.: Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82-96 (2006).
18. US Department of Health and Human Services and US Department of Agriculture: Dietary Guidelines for Americans. Government Printing Office, Washington, DC (2005).
19. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25, 2165-2171 (2002).
20. Pi-Sunyer X, Blackburn G, Brancati FL et al.: Reduction in weight and cardiovascular disease risk factors in individuals with Type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30, 1374-1383 (2007).
21. Koertge J, Weidner G, Elliott-Eller M et al.: Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. Am. J. Cardiol. 91, 1316-1322 (2003).
22. Esposito K, Marfella R, Ciotola M et al.: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440-1446 (2004).
23. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293, 43-53 (2005).
24. Gardner CD, Kiazand A, Alhassan S et al.: Comparison of the Atkins, Zone, Ornish, and LEARN Diets for change in weight and related risk factors among overweight premenopausal women: the A to Z weight loss study: a randomized trial. JAMA 297, 969-977 (2007).
25. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS: Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA 297, 2092-2102 (2007).
26. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS: Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 292, 2482-2490 (2004).
27. Volek JS, Fernandez ML, Feinman RD, Phinney SD: Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog. Lipid Res. 47, 307-318 (2008).
28. Westman EC, Yancy JWS, Olsen MK, Dudley T, Guyton JR: Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int. J. Cardiol. 110, 212-216 (2006).
29. Marshall DA, Vernalis MN, Remaley AT et al.: The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease. Am. Heart J. 151, 484-491 (2006).
30. Wing RR, Phelan S: Long-term weight loss maintenance. Am. J. Clin. Nutr. 82, S222-S225 (2005).
31. Keys A: The relation in man between cholesterol levels in the diet and in the blood. Science 112, 79-81 (1950).
32. Mensink RP, Zock PL, Kester ADM, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146-1155 (2003).
33. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch. Intern. Med. 148, 36-69 (1988).
34. The Expert Panel: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269, 3015-3023 (1993).
35. Schaefer EJ, Lamon-Fava S, Ausman LM et al.: Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am. J. Clin. Nutr. 65, 823-830 (1997).
36. Jenkins DJA, Kendall CWC, Faulkner D et al.: A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596-1604 (2002).
37. Jenkins DJA, Kendall CWC, Marchie A et al.: Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510 (2003).
38. Jenkins DJA, Kendall CWC, Marchie A et al.: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am. J. Clin. Nutr. 81, 380-387 (2005).
39. Obarzanek E, Sacks FM, Vollmer WM et al.: Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am. J. Clin. Nutr. 74, 80-89 (2001).
40. Howard BV, Van Horn L, Hsia J et al.: Low-fat dietary pattern and risk of cardiovascular disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295, 655-666 (2006).
41. Appel LJ, Sacks FM, Carey VJ et al.: Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294, 2455-2464 (2005).
42. Estruch R, Martinez-Gonzalez MA, Corella D et al.: Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann. Intern. Med. 145, 1-11 (2006).
43. Putnam JJ, Allshouse JA: Food consumption, prices and expenditures. 1970-1997. US Department of Agriculture, Washington DC, USA (1999).
44. Pawlak DB, Ebbeling CB, Ludwig DS: Should obese patients be counselled to follow a low-glycaemic index diet? Yes. Obes. Rev. 3, 235-243 (2002).
45. Nordmann AJ, Nordmann A, Briel M et al.: Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166, 285-293 (2006).
46. Westman EC, Feinman RD, Mavropoulos JC et al.: Low-carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. 86, 276-284 (2007).
47. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT: Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am. J. Clin. Nutr. 83, 1025-1031 (2006).
48. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836-843 (2000).
49. Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103, 1813-1818 (2001).
50. Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97, 2007-2011 (1998).
51. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557-1565 (2002).
52. Smith SC Jr, Anderson JL, Cannon RO III et al.: CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the clinical practice discussion group. Circulation 110, E550-E553 (2004).
53. Frohlich M, Imhof A, Berg G et al.: Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23, 1835-1839 (2000).
54. Tamakoshi K, Yatsuya H, Kondo T et al.: The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int. J. Obes. Relat. Metab. Disord. 27, 443-449 (2003).
55. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131-2135 (1999).
56. O'Brien KD, Brehm BJ, Seeley RJ et al.: Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects. J. Clin. Endocrinol. Metab. 90, 2244-2249 (2005).
57. Selvin E, Paynter NP, Eringer TP: The effect of weight loss on C-reactive protein: a systematic review. Arch. Intern. Med. 167, 31-39 (2007).
58. Seshadri P, Iqbal N, Stern L et al.: A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am. J. Med. 117, 398-405 (2004).
59. King DE, Egan BM, Geesey ME: Relation of dietary fat and fiber to elevation of C-reactive protein. Am. J. Cardiol. 92, 1335-1339 (2003).
60. Ma Y, Griffith JA, Chasan-Taber L et al.: Association between dietary fiber and serum C-reactive protein. Am. J. Clin. Nutr. 83, 760-766 (2006).
61. Ajani UA, Ford ES, Mokdad AH: Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey Data. J. Nutr. 134, 1181-1185 (2004).
62. Zhao G, Etherton TD, Martin KR et al.: Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134, 2991-2997 (2004).
63. Basu A, Devaraj S, Jialal I: Dietary factors that promote or retard inflammation. Arterioscler. Thromb. Vasc. Biol. 26, 995-1001 (2006).
64. Jenkins DJ, Kendall CW, Marchie A et al.: Direct comparison of dietary portfolio vs steno on C-reactive protein. Eur. J. Clin. Nutr. 59, 851-860 (2005).
65. King DE, Egan BM, Woolson RF et al.: Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch. Intern. Med. 167, 502-506 (2007).
66. Jansen S, Lopez-Miranda J, Salas J et al.: Plasma lipid response to hypolipidemic diets in young healthy non-obese men varies with body mass index. J. Nutr. 128, 1144-1149 (1998).
67. Lefevre M, Champagne CM, Tulley RT, Rood JC, Most MM: Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am. J. Clin Nutr. 82, 957-963 (2005).
68. Erlinger TP, Miller ER III, Charleston J, Appel LJ: Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation 108, 150-154 (2003).
69. Hilpert KF, Kris-Etherton PM, West SG: Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J. Nutr. 135, 1075-1079 (2005).
70. Berglund L, Lefevre M, Ginsberg HN et al.: Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am. J. Clin. Nutr. 86, 1611-1620 (2007).
71. Jenkins DJA, Kendall CWC, Faulkner DA et al.: Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am. J. Clin. Nutr. 83, 582-591 (2006).
72. Varady KA, Jones PJH: Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J. Nutr. 135, 1829-1835 (2005).
73. Esmaillzadeh A, Kimiagar M, Mehrabi Y et al.: Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am. J. Clin. Nutr. 84, 1489-1497 (2006).
74. Gao X, Bermudez OI, Tucker KL: Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J. Nutr. 134, 913-918 (2004).
75. Jiang R, Jacobs DR Jr, Mayer-Davis E et al.: Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 163, 222-231 (2006).
76. Liu S, Manson JE, Buring JE et al.: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am. J. Clin. Nutr. 75, 492-498 (2002).
77. Zampelas A, Panagiotakos DB, Pitsavos C et al.: Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA Study. J. Am. Coll. Cardiol. 46, 120-124 (2005).